Coral Genomics

About:

Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication.

Website: https://www.coralgenomics.com

Top Investors: Y Combinator, 8VC, National Institutes of Health, Soma Capital, National Human Genome Research Institute

Description:

Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication for a particular patient focusing on autoimmune conditions such as Inflammatory Bowel Disease and Rheumatoid Arthritis. It has also identified a unique population of non-responder patients and is working with drug developers to address this unmet medical need.